Back to search results
Recruiting

Atopic Dermatitis (Eczema)

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

FCAB | {{ defaultRegistry.registryAnchorText }} NCT03831191 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The reason for this study is to see if the study drug LY3375880 is safe and effective in adults with moderate-to-severe atopic dermatitis (AD).

Time Commitment

The study will last about 65 weeks and may include up to 18 visits.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18+ years
  • Participants must have diagnosis of AD for at least 12 months according to American Academy of Dermatology criteria
  • Participants must have moderate to severe AD at screening and randomization
  • Participants must have inadequate response to topical medications within 6 months of screening (or history of intolerance)
  • Participants must not have concurrent treatment with topical or systemic treatments for AD

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.